Biomea Fusion Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Biomea Fusion Inc.
- Company name
- Biomea Fusion Inc.
- Organisation type
- Industry
- Registered legal name
- Biomea Fusion, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001840439
Related records
Trials (9)
- A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
- Food Effect Study in Healthy Volunteers
- Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
- Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
- Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
- Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer